Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults

BACKGROUND: We conducted a prospective cohort study at Kaiser Permanente Southern California to evaluate the relative vaccine effectiveness (rVE) of a booster dose vs 2-dose primary series of messenger RNA (mRNA)-1273 in immunocompetent individuals. METHODS: Immunocompetent adults who received a boo...

Descripción completa

Detalles Bibliográficos
Autores principales: Florea, Ana, Sy, Lina S, Qian, Lei, Ackerson, Bradley K, Luo, Yi, Tubert, Julia E, Lee, Gina S, Ku, Jennifer H, Bruxvoort, Katia J, Talarico, Carla A, Qiu, Sijia, Tian, Yun, Tseng, Hung Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619452/
https://www.ncbi.nlm.nih.gov/pubmed/36134518
http://dx.doi.org/10.1093/cid/ciac785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619452/
https://www.ncbi.nlm.nih.gov/pubmed/36134518
http://dx.doi.org/10.1093/cid/ciac785

Ejemplares similares